Insider Trading activities of Boston Scientific Corp insiders. , Part 7

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005. The reporting company's ticker symbol is BSX. The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $23,762,101.
The total value of stock sales since 2005 is $867,620,178.
The total value of stock option exercises since 2005 is $78,587,333.



Table 2. Detailed insider stock purchases, sales, and option exercises of Boston Scientific Corp insiders (BSX) , Part 7
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-06-01 Abele John E (Director) Sale 75,000 6.03 452,325
2010-05-28 Nicholas Peter M (Director) Sale 25,000 6.13 153,250
2010-05-28 Abele John E (Director) Sale 75,000 6.12 459,150
2010-05-27 Nicholas Peter M (Director) Sale 25,000 6.10 152,550
2010-05-27 Abele John E (Director) Sale 75,000 6.10 457,650
2010-05-26 Nicholas Peter M (Director) Sale 25,000 6.10 152,500
2010-05-26 Abele John E (Director) Sale 75,000 6.10 457,350
2010-05-25 Nicholas Peter M (Director) Sale 25,000 6.00 149,900
2010-05-25 Abele John E (Director) Sale 75,000 6.01 450,899
2010-05-24 Nicholas Peter M (Director) Sale 25,000 6.33 158,150
2010-05-24 Abele John E (Director) Sale 75,000 6.32 474,225
2010-05-21 Nicholas Peter M (Director) Sale 25,000 6.33 158,375
2010-05-21 Abele John E (Director) Sale 75,000 6.31 473,550
2010-05-20 Nicholas Peter M (Director) Sale 25,000 6.46 161,375
2010-05-20 Abele John E (Director) Sale 75,000 6.45 483,750
2010-05-19 Nicholas Peter M (Director) Sale 25,000 6.64 165,925
2010-05-19 Abele John E (Director) Sale 75,000 6.64 497,850
2010-05-18 Nicholas Peter M (Director) Sale 25,000 6.71 167,750
2010-05-18 Abele John E (Director) Sale 75,000 6.69 501,825
2010-05-17 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 2,963 6.82 20,207
2010-05-17 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 2,963 6.12 18,148
2010-05-17 Nicholas Peter M (Director) Sale 25,000 6.69 167,350
2010-05-17 Abele John E (Director) Sale 75,000 6.69 502,050
2010-05-10 Colen Fred (EVP & Chief Technology Officer) Option Ex 11,375 .00 0
2010-05-07 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 2,350 .00 0
2010-05-03 Nicholas Peter M (Director) Sale 25,000 6.86 171,500
2010-05-03 Abele John E (Director) Sale 75,000 6.86 514,650
2010-05-01 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 14,750 .00 0
2010-04-29 Connors Nelda J (Director) Buy 2,500 7.00 17,500
2010-04-28 Nicholas Peter M (Director) Sale 25,000 7.00 174,925
2010-04-28 Abele John E (Director) Sale 75,000 7.00 524,850
2010-04-27 Nicholas Peter M (Director) Sale 25,000 7.15 178,700
2010-04-27 Abele John E (Director) Sale 75,000 7.13 534,750
2010-04-26 Nicholas Peter M (Director) Sale 25,000 7.13 178,175
2010-04-26 Abele John E (Director) Sale 75,000 7.13 534,900
2010-04-23 Nicholas Peter M (Director) Sale 25,000 7.20 179,875
2010-04-23 Abele John E (Director) Sale 75,000 7.20 539,700
2010-04-22 Nicholas Peter M (Director) Sale 25,000 7.18 179,500
2010-04-22 Abele John E (Director) Sale 75,000 7.18 538,575
2010-04-21 Nicholas Peter M (Director) Sale 25,000 7.24 181,100
2010-04-21 Abele John E (Director) Sale 75,000 7.24 543,300
2010-04-20 Nicholas Peter M (Director) Sale 25,000 7.34 183,400
2010-04-20 Abele John E (Director) Sale 75,000 7.33 550,125
2010-04-19 Nicholas Peter M (Director) Sale 50,000 7.36 367,750
2010-04-19 Abele John E (Director) Sale 150,000 7.35 1,102,800
2010-04-16 Nicholas Peter M (Director) Sale 25,000 7.39 184,700
2010-04-16 Abele John E (Director) Sale 75,000 7.38 553,350
2010-04-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 2,963 7.12 21,096
2010-04-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 2,963 6.12 18,148
2010-04-15 Nicholas Peter M (Director) Sale 25,000 7.14 178,500
2010-04-15 Abele John E (Director) Sale 75,000 7.14 535,350
2010-04-14 Nicholas Peter M (Director) Sale 25,000 7.08 177,100
2010-04-14 Abele John E (Director) Sale 75,000 7.09 531,750
2010-04-13 Nicholas Peter M (Director) Sale 25,000 6.91 172,725
2010-04-13 Abele John E (Director) Sale 75,000 6.91 518,025
2010-04-12 Nicholas Peter M (Director) Sale 25,000 7.02 175,450
2010-04-12 Abele John E (Director) Sale 75,000 7.01 526,125
2010-04-09 Nicholas Peter M (Director) Sale 25,000 6.95 173,725
2010-04-09 Abele John E (Director) Sale 75,000 6.95 520,950
2010-04-08 Nicholas Peter M (Director) Sale 25,000 7.04 176,000
2010-04-08 Abele John E (Director) Sale 75,000 7.04 527,850
2010-04-07 Nicholas Peter M (Director) Sale 25,000 7.11 177,800
2010-04-07 Abele John E (Director) Sale 75,000 7.11 533,175
2010-04-06 Nicholas Peter M (Director) Sale 25,000 7.15 178,700
2010-04-06 Abele John E (Director) Sale 75,000 7.15 536,100
2010-04-05 Nicholas Peter M (Director) Sale 25,000 7.20 180,025
2010-04-05 Abele John E (Director) Sale 75,000 7.20 539,850
2010-04-01 Nicholas Peter M (Director) Sale 25,000 7.22 180,475
2010-04-01 Abele John E (Director) Sale 75,000 7.22 541,200
2010-03-31 Nicholas Peter M (Director) Sale 25,000 7.21 180,325
2010-03-31 Abele John E (Director) Sale 75,000 7.21 540,900
2010-03-30 Nicholas Peter M (Director) Sale 25,000 7.14 178,600
2010-03-30 Abele John E (Director) Sale 75,000 7.14 535,350
2010-03-29 Nicholas Peter M (Director) Sale 25,000 7.05 176,350
2010-03-29 Abele John E (Director) Sale 75,000 7.05 528,525
2010-03-26 Nicholas Peter M (Director) Sale 25,000 6.98 174,525
2010-03-26 Abele John E (Director) Sale 75,000 6.98 523,275
2010-03-25 Nicholas Peter M (Director) Sale 25,000 6.97 174,350
2010-03-25 Abele John E (Director) Sale 75,000 6.97 522,900
2010-03-24 Nicholas Peter M (Director) Sale 25,000 7.04 175,975
2010-03-24 Abele John E (Director) Sale 75,000 7.04 527,625
2010-03-23 Nicholas Peter M (Director) Sale 25,000 6.95 173,625
2010-03-23 Abele John E (Director) Sale 75,000 6.92 518,850
2010-03-22 Nicholas Peter M (Director) Sale 25,000 7.01 175,300
2010-03-22 Abele John E (Director) Sale 75,000 7.03 527,175
2010-03-19 Nicholas Peter M (Director) Sale 25,000 7.12 178,125
2010-03-19 Abele John E (Director) Sale 75,000 7.12 534,375
2010-03-18 Nicholas Peter M (Director) Sale 25,000 6.90 172,600
2010-03-18 Abele John E (Director) Sale 75,000 6.92 519,000
2010-03-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 2,963 6.40 18,963
2010-03-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 2,963 6.12 18,148
2010-03-01 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 3,375 .00 0
2010-02-24 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 1,326 .00 0
2010-02-24 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 1,326 .00 0
2010-02-24 Phalen Michael P. (SVP & President, Endoscopy) Option Ex 4,699 .00 0
2010-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2010-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2010-02-24 Kucheman William (EVP, Cardiology) Option Ex 3,012 .00 0
2010-02-24 Pucel Kenneth (EVP, Global Operations) Option Ex 3,012 .00 0
2010-02-24 Burns Brian R (SVP - Global Quality) Option Ex 3,615 .00 0
2010-02-24 Gilbert James (EVP, Strategy & Business Dev) Option Ex 3,314 .00 0
2010-02-24 Leno Sam R (CFO & EVP Finance & IS) Option Ex 6,024 .00 0
2010-02-24 Capello Jeffrey D (SVP, Chief Accounting Officer) Option Ex 3,012 .00 0
2010-02-24 Colen Fred (EVP & Chief Technology Officer) Option Ex 3,012 .00 0
2010-02-16 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 2,920 .00 0
2010-02-16 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 1,635 .00 0
2010-02-12 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 1,996 .00 0
2010-02-12 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 998 .00 0
2010-02-12 Phalen Michael P. (SVP & President, Endoscopy) Option Ex 3,274 .00 0
2010-02-12 Lance Jean Fitterer (Chief Compliance Officer) Option Ex 3,194 .00 0
2010-02-12 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 3,993 .00 0
2010-02-12 Mcfaul David W (SVP, International) Option Ex 2,795 .00 0
2010-02-12 Kucheman William (EVP, Cardiology) Option Ex 7,986 .00 0
2010-02-12 Pucel Kenneth (EVP, Global Operations) Option Ex 13,178 .00 0
2010-02-12 Burns Brian R (SVP - Global Quality) Option Ex 10,806 .00 0
2010-02-12 Gilbert James (EVP, Strategy & Business Dev) Option Ex 3,993 .00 0
2010-02-12 Leno Sam R (CFO & EVP Finance & IS) Option Ex 10,982 .00 0
2010-02-12 Paul Donovan (SVP, Corporate Communications) Option Ex 10,406 .00 0
2010-02-12 Colen Fred (EVP & Chief Technology Officer) Option Ex 19,468 .00 0
2010-02-12 Moreci Stephen F (SVP, Global Sales Operations) Option Ex 2,995 .00 0
2010-01-04 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 588 .00 0
2009-11-13 Nicholas Peter M (Director) Sale 205,482 8.29 1,702,418
2009-11-12 Nicholas Peter M (Director) Sale 150,000 8.29 1,243,950
2009-11-11 Nicholas Peter M (Director) Sale 150,000 8.34 1,251,450
2009-11-10 Nicholas Peter M (Director) Sale 150,000 8.21 1,230,900
2009-11-09 Nicholas Peter M (Director) Sale 200,000 8.19 1,638,800
2009-11-06 Nicholas Peter M (Director) Sale 150,000 8.08 1,212,000
2009-11-05 Nicholas Peter M (Director) Sale 250,000 8.01 2,002,500
2009-11-02 Mcfaul David W (Senior VP International) Option Ex 2,645 .00 0
2009-11-02 Kucheman William (SVP & Group President) Option Ex 6,500 .00 0
2009-11-02 Pucel Kenneth (EVP, Operations) Option Ex 6,500 .00 0
2009-10-30 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 2,290 .00 0
2009-10-30 Mcfaul David W (Senior VP International) Option Ex 9,332 .00 0
2009-10-29 Nicholas Peter M (Director) Sale 50,000 8.21 410,300
2009-10-29 Abele John E (Director) Sale 125,000 8.23 1,028,624
2009-10-28 Nicholas Peter M (Director) Sale 50,000 8.22 411,050
2009-10-28 Abele John E (Director) Sale 100,000 8.23 823,100
2009-10-27 Nicholas Peter M (Director) Sale 50,000 8.43 421,500
2009-10-27 Abele John E (Director) Sale 100,000 8.44 843,699
2009-10-26 Nicholas Peter M (Director) Sale 50,000 8.50 424,899
2009-10-26 Abele John E (Director) Sale 100,000 8.62 861,800
2009-10-23 Abele John E (Director) Sale 100,000 8.62 861,600
2009-10-22 Abele John E (Director) Sale 50,000 8.40 420,000
2009-10-21 Nicholas Peter M (Director) Sale 100,000 8.35 835,300
2009-10-20 Nicholas Peter M (Director) Sale 100,000 8.98 898,100
2009-10-19 Nicholas Peter M (Director) Sale 100,000 10.19 1,018,800
2009-10-16 Nicholas Peter M (Director) Sale 100,000 10.03 1,003,300
2009-10-15 Nicholas Peter M (Director) Sale 100,000 10.06 1,005,700
2009-10-14 Nicholas Peter M (Director) Sale 100,000 10.03 1,002,699
2009-10-13 Nicholas Peter M (Director) Sale 100,000 9.94 993,600

Insider trading activities including stock purchases, stock sales, and option exercises of BSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Boston Scientific Corp (symbol BSX, CIK number 885725) see the Securities and Exchange Commission (SEC) website.